vs
Cooper Companies (The)（COO）与亨廷顿·英格尔斯工业（HII）财务数据对比。点击上方公司名可切换其他公司
亨廷顿·英格尔斯工业的季度营收约是Cooper Companies (The)的1.6倍（$1.7B vs $1.1B），亨廷顿·英格尔斯工业净利率更高（8.9% vs 7.9%，领先1.0%），亨廷顿·英格尔斯工业同比增速更快（13.8% vs 4.6%），Cooper Companies (The)自由现金流更多（$149.9M vs $-461.0M），过去两年Cooper Companies (The)的营收复合增速更高（6.9% vs -25.2%）
CooperCompanies是总部位于美国加利福尼亚州圣拉蒙的全球医疗设备企业，旗下设有两大业务单元：主营隐形眼镜生产的库博光学，以及面向女性健康市场提供医疗设备、生育及基因组相关产品的库博外科。
亨廷顿·英格尔斯工业（简称HII）是美国规模最大的军用造船企业，同时面向政府及行业合作伙伴提供专业服务。公司于2011年3月31日从诺斯罗普·格鲁曼公司分拆成立，在防务装备建造及配套服务领域拥有深厚技术积累与行业资源。
COO vs HII — 直观对比
营收规模更大
HII
是对方的1.6倍
$1.1B
营收增速更快
HII
高出9.2%
4.6%
净利率更高
HII
高出1.0%
7.9%
自由现金流更多
COO
多$610.9M
$-461.0M
两年增速更快
COO
近两年复合增速
-25.2%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $1.7B |
| 净利润 | $84.6M | $149.0M |
| 毛利率 | 61.1% | — |
| 营业利润率 | 13.2% | 9.3% |
| 净利率 | 7.9% | 8.9% |
| 营收同比 | 4.6% | 13.8% |
| 净利润同比 | -28.0% | — |
| 每股收益（稀释后） | $0.42 | $3.79 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收COOHII
| Q1 26 | — | $1.7B | ||
| Q4 25 | $1.1B | $3.5B | ||
| Q3 25 | $1.1B | $3.2B | ||
| Q2 25 | $1.0B | $3.1B | ||
| Q1 25 | $964.7M | $2.7B | ||
| Q4 24 | $1.0B | $3.0B | ||
| Q3 24 | $1.0B | $2.7B | ||
| Q2 24 | $942.6M | $3.0B |
净利润COOHII
| Q1 26 | — | $149.0M | ||
| Q4 25 | $84.6M | $159.0M | ||
| Q3 25 | $98.3M | $145.0M | ||
| Q2 25 | $87.7M | $152.0M | ||
| Q1 25 | $104.3M | $149.0M | ||
| Q4 24 | $117.5M | $123.0M | ||
| Q3 24 | $104.7M | $101.0M | ||
| Q2 24 | $88.9M | $173.0M |
毛利率COOHII
| Q1 26 | — | — | ||
| Q4 25 | 61.1% | — | ||
| Q3 25 | 65.3% | — | ||
| Q2 25 | 67.8% | — | ||
| Q1 25 | 68.4% | — | ||
| Q4 24 | 66.5% | — | ||
| Q3 24 | 66.1% | — | ||
| Q2 24 | 67.0% | — |
营业利润率COOHII
| Q1 26 | — | 9.3% | ||
| Q4 25 | 13.2% | 4.9% | ||
| Q3 25 | 16.6% | 5.0% | ||
| Q2 25 | 18.4% | 5.3% | ||
| Q1 25 | 18.9% | 5.9% | ||
| Q4 24 | 19.5% | 3.7% | ||
| Q3 24 | 19.2% | 3.0% | ||
| Q2 24 | 17.2% | 6.3% |
净利率COOHII
| Q1 26 | — | 8.9% | ||
| Q4 25 | 7.9% | 4.6% | ||
| Q3 25 | 9.3% | 4.5% | ||
| Q2 25 | 8.7% | 4.9% | ||
| Q1 25 | 10.8% | 5.4% | ||
| Q4 24 | 11.5% | 4.1% | ||
| Q3 24 | 10.4% | 3.7% | ||
| Q2 24 | 9.4% | 5.8% |
每股收益（稀释后）COOHII
| Q1 26 | — | $3.79 | ||
| Q4 25 | $0.42 | $4.06 | ||
| Q3 25 | $0.49 | $3.68 | ||
| Q2 25 | $0.44 | $3.86 | ||
| Q1 25 | $0.52 | $3.79 | ||
| Q4 24 | $0.59 | $3.15 | ||
| Q3 24 | $0.52 | $2.56 | ||
| Q2 24 | $0.44 | $4.38 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $110.6M | $216.0M |
| 总债务越低越好 | $2.5B | $2.7B |
| 股东权益账面价值 | $8.2B | $5.1B |
| 总资产 | $12.4B | $12.5B |
| 负债/权益比越低杠杆越低 | 0.30× | 0.52× |
8季度趋势，按日历期对齐
现金及短期投资COOHII
| Q1 26 | — | $216.0M | ||
| Q4 25 | $110.6M | — | ||
| Q3 25 | $124.9M | — | ||
| Q2 25 | $116.2M | — | ||
| Q1 25 | $100.9M | — | ||
| Q4 24 | $107.6M | — | ||
| Q3 24 | $109.7M | — | ||
| Q2 24 | $112.4M | — |
总债务COOHII
| Q1 26 | — | $2.7B | ||
| Q4 25 | $2.5B | $2.7B | ||
| Q3 25 | $2.4B | — | ||
| Q2 25 | $2.5B | — | ||
| Q1 25 | $2.5B | — | ||
| Q4 24 | $2.6B | $2.7B | ||
| Q3 24 | $2.6B | — | ||
| Q2 24 | $2.7B | — |
股东权益COOHII
| Q1 26 | — | $5.1B | ||
| Q4 25 | $8.2B | $5.1B | ||
| Q3 25 | $8.4B | $5.0B | ||
| Q2 25 | $8.3B | $4.9B | ||
| Q1 25 | $8.1B | $4.8B | ||
| Q4 24 | $8.1B | $4.7B | ||
| Q3 24 | $7.9B | $4.2B | ||
| Q2 24 | $7.8B | $4.2B |
总资产COOHII
| Q1 26 | — | $12.5B | ||
| Q4 25 | $12.4B | $12.7B | ||
| Q3 25 | $12.4B | $12.3B | ||
| Q2 25 | $12.4B | $12.1B | ||
| Q1 25 | $12.2B | $12.1B | ||
| Q4 24 | $12.3B | $12.1B | ||
| Q3 24 | $12.1B | $11.1B | ||
| Q2 24 | $12.0B | $11.3B |
负债/权益比COOHII
| Q1 26 | — | 0.52× | ||
| Q4 25 | 0.30× | 0.53× | ||
| Q3 25 | 0.29× | — | ||
| Q2 25 | 0.30× | — | ||
| Q1 25 | 0.31× | — | ||
| Q4 24 | 0.32× | 0.58× | ||
| Q3 24 | 0.33× | — | ||
| Q2 24 | 0.34× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $247.9M | $-390.0M |
| 自由现金流经营现金流 - 资本支出 | $149.9M | $-461.0M |
| 自由现金流率自由现金流/营收 | 14.1% | -27.7% |
| 资本支出强度资本支出/营收 | 9.2% | 4.4% |
| 现金转化率经营现金流/净利润 | 2.93× | -2.62× |
| 过去12个月自由现金流最近4个季度 | $433.7M | $795.0M |
8季度趋势，按日历期对齐
经营现金流COOHII
| Q1 26 | — | $-390.0M | ||
| Q4 25 | $247.9M | $650.0M | ||
| Q3 25 | $261.4M | $118.0M | ||
| Q2 25 | $96.2M | $823.0M | ||
| Q1 25 | $190.6M | $-395.0M | ||
| Q4 24 | $268.1M | $391.0M | ||
| Q3 24 | $207.5M | $213.0M | ||
| Q2 24 | $111.0M | $-9.0M |
自由现金流COOHII
| Q1 26 | — | $-461.0M | ||
| Q4 25 | $149.9M | $516.0M | ||
| Q3 25 | $164.5M | $13.0M | ||
| Q2 25 | $18.1M | $727.0M | ||
| Q1 25 | $101.2M | $-462.0M | ||
| Q4 24 | $128.1M | $277.0M | ||
| Q3 24 | $118.5M | $125.0M | ||
| Q2 24 | $36.9M | $-99.0M |
自由现金流率COOHII
| Q1 26 | — | -27.7% | ||
| Q4 25 | 14.1% | 14.8% | ||
| Q3 25 | 15.5% | 0.4% | ||
| Q2 25 | 1.8% | 23.6% | ||
| Q1 25 | 10.5% | -16.9% | ||
| Q4 24 | 12.6% | 9.2% | ||
| Q3 24 | 11.8% | 4.5% | ||
| Q2 24 | 3.9% | -3.3% |
资本支出强度COOHII
| Q1 26 | — | 4.4% | ||
| Q4 25 | 9.2% | 3.9% | ||
| Q3 25 | 9.1% | 3.3% | ||
| Q2 25 | 7.8% | 3.1% | ||
| Q1 25 | 9.3% | 2.5% | ||
| Q4 24 | 13.7% | 3.8% | ||
| Q3 24 | 8.9% | 3.2% | ||
| Q2 24 | 7.9% | 3.0% |
现金转化率COOHII
| Q1 26 | — | -2.62× | ||
| Q4 25 | 2.93× | 4.09× | ||
| Q3 25 | 2.66× | 0.81× | ||
| Q2 25 | 1.10× | 5.41× | ||
| Q1 25 | 1.83× | -2.65× | ||
| Q4 24 | 2.28× | 3.18× | ||
| Q3 24 | 1.98× | 2.11× | ||
| Q2 24 | 1.25× | -0.05× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
COO
| Sphere Other | $365.0M | 34% |
| Toric And Multifocal | $344.7M | 32% |
| Office And Surgical | $214.5M | 20% |
| Fertility | $140.9M | 13% |
HII
暂无分部数据
